EE9900457A - Trovafloksatsiini vesiniksoolade valmistamise protsess - Google Patents

Trovafloksatsiini vesiniksoolade valmistamise protsess

Info

Publication number
EE9900457A
EE9900457A EEP199900457A EEP9900457A EE9900457A EE 9900457 A EE9900457 A EE 9900457A EE P199900457 A EEP199900457 A EE P199900457A EE P9900457 A EEP9900457 A EE P9900457A EE 9900457 A EE9900457 A EE 9900457A
Authority
EE
Estonia
Prior art keywords
trovafloxacin
preparation
hydrogen salts
salts
hydrogen
Prior art date
Application number
EEP199900457A
Other languages
English (en)
Inventor
Norris Timothy
Robert Rose Peter
Michael Devries Keith
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE9900457A publication Critical patent/EE9900457A/et
Publication of EE04118B1 publication Critical patent/EE04118B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
EEP199900457A 1998-09-03 1999-09-02 Trovafloksatsiini vesiniksoolad ja nende valmistamise protsess EE04118B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (2)

Publication Number Publication Date
EE9900457A true EE9900457A (et) 2000-04-17
EE04118B1 EE04118B1 (et) 2003-08-15

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900457A EE04118B1 (et) 1998-09-03 1999-09-02 Trovafloksatsiini vesiniksoolad ja nende valmistamise protsess

Country Status (40)

Country Link
US (1) US6359137B1 (et)
EP (1) EP0989119A1 (et)
JP (1) JP3354526B2 (et)
KR (1) KR20000022858A (et)
CN (1) CN1248580A (et)
AP (1) AP1118A (et)
AR (1) AR021475A1 (et)
AU (1) AU761035B2 (et)
BG (1) BG103703A (et)
BR (1) BR9904082A (et)
CA (1) CA2281244C (et)
CO (1) CO5251466A1 (et)
EA (1) EA002340B1 (et)
EE (1) EE04118B1 (et)
GE (1) GEP20022785B (et)
GT (1) GT199900142A (et)
HN (1) HN1999000141A (et)
HR (1) HRP990274A2 (et)
HU (1) HUP9902967A3 (et)
ID (1) ID23718A (et)
IL (1) IL131614A0 (et)
IN (1) IN191583B (et)
IS (1) IS5168A (et)
MA (1) MA24966A1 (et)
MY (1) MY130800A (et)
NO (1) NO994261L (et)
NZ (1) NZ337605A (et)
OA (1) OA11152A (et)
PA (1) PA8481001A1 (et)
PE (1) PE20001026A1 (et)
PL (1) PL335246A1 (et)
SG (1) SG74748A1 (et)
SK (1) SK116599A3 (et)
SV (1) SV1999000144A (et)
TN (1) TNSN99164A1 (et)
TR (1) TR199902138A2 (et)
TW (1) TW520369B (et)
UY (1) UY25686A1 (et)
YU (1) YU43199A (et)
ZA (1) ZA995630B (et)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
EP0740667A1 (en) * 1994-01-18 1996-11-06 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
CA2223404C (en) * 1995-06-06 2001-01-16 Thomas A. Morris Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
PL325170A1 (en) * 1995-08-29 1998-07-06 Pfizer Bipolar forms of throwaflocacin
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas

Also Published As

Publication number Publication date
CA2281244C (en) 2003-05-20
EE04118B1 (et) 2003-08-15
NO994261L (no) 2000-03-06
EA199900708A2 (ru) 2000-04-24
HN1999000141A (es) 2000-06-19
EP0989119A1 (en) 2000-03-29
BG103703A (bg) 2001-08-31
EA002340B1 (ru) 2002-04-25
GT199900142A (es) 2001-02-15
SK116599A3 (en) 2000-05-16
NO994261D0 (no) 1999-09-02
AU4482699A (en) 2000-03-16
SG74748A1 (en) 2000-08-22
NZ337605A (en) 2001-03-30
PE20001026A1 (es) 2000-10-11
TW520369B (en) 2003-02-11
HU9902967D0 (en) 1999-10-28
YU43199A (sh) 2002-11-15
AR021475A1 (es) 2002-07-24
JP2000086658A (ja) 2000-03-28
TNSN99164A1 (fr) 2005-11-10
BR9904082A (pt) 2000-09-12
CO5251466A1 (es) 2003-02-28
PL335246A1 (en) 2000-03-13
GEP20022785B (en) 2002-09-25
AP9901667A0 (en) 1999-12-31
IN191583B (et) 2003-12-06
AP1118A (en) 2002-11-21
PA8481001A1 (es) 2000-09-29
SV1999000144A (es) 2000-09-05
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
MY130800A (en) 2007-07-31
JP3354526B2 (ja) 2002-12-09
CA2281244A1 (en) 2000-03-03
TR199902138A2 (xx) 2000-04-21
EA199900708A3 (ru) 2000-08-28
ZA995630B (en) 2001-03-01
HUP9902967A3 (en) 2000-11-28
MA24966A1 (fr) 2000-04-01
US6359137B1 (en) 2002-03-19
AU761035B2 (en) 2003-05-29
IL131614A0 (en) 2001-01-28
HRP990274A2 (en) 2000-10-31
IS5168A (is) 2000-03-04
ID23718A (id) 2000-05-11
HUP9902967A2 (hu) 2000-05-28
CN1248580A (zh) 2000-03-29
UY25686A1 (es) 2000-03-31

Similar Documents

Publication Publication Date Title
PL349894A1 (en) An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine
FI20000564A (fi) Menetelmä nanolaminaattien valmistamiseksi
EE200200183A (et) Meetod polüisobuteenfenooli sisaldavate Mannichi aduktide saamiseks
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
EE200100383A (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
DK0994091T3 (da) Fremgangsmåde til fremstilling methanol
IL156145A0 (en) Process for the preparation of phenethylamine derivatives
IT1298096B1 (it) Procedimento per la produzione di gamma-butirrolattone
FR2818979B1 (fr) Procede de preparation d'imidaclopride
NO995851D0 (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK1240173T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin
ITMI981796A0 (it) Procedimento per la preparazione di r-(-)-carnitina
EE9900457A (et) Trovafloksatsiini vesiniksoolade valmistamise protsess
FR2791669B1 (fr) Procede de preparation du fluoroformiate de tertiobutyle
DK1012143T3 (da) Fremgangsmåde til fremstilling af 1-phenylpyrazolin-3-carboxylsyrederivater
FI991294A (fi) Nikkelirikasteen valmistusmenetelmä
NO20025385L (no) Fremgangsmate for fremstilling av sulfonylbenzoylguanidiniumsalter
TH34294B (th) กระบวนการสำหรับการเตรียมคลอโรเบบโซซาโซล
NO20013453D0 (no) Fremgangsmåte for fremstilling av salter av cyanobenzylaminer
DK0949237T3 (da) Fremgangsmåde til fremstilling af dihydrocitral
FI980877A (fi) Menetelmä ksyloosin valmistamiseksi
IL147918A0 (en) Process for the preparation of isotretinoin
IT1308677B1 (it) Procedimento per produrre 2,2,6,6-tetrametil-4-piperidone

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20040902